The global cell & gene therapy (CGT) CDMO market is anticipated to witness a CAGR of ~25% to reach ~$5 billion by 2025. This growth will be fueled by the rising incidence of cancer and other targeted diseases, rapidly expanding research on CGTs, substantial funding by VCs and technological innovations.